Tetsu Hayashida Selected Research

Tetsu Hayashida Research Topics

Disease

29	Neoplasms (Cancer) 03/2024 - 07/2005
29	Breast Neoplasms (Breast Cancer) 02/2024 - 07/2006
6	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 07/2010
5	Neoplasm Metastasis (Metastasis) 08/2020 - 01/2010
3	Triple Negative Breast Neoplasms 02/2024 - 02/2011
2	Stomach Neoplasms (Stomach Cancer) 03/2021 - 03/2019
2	Acute Liver Failure (Fulminant Hepatic Failure) 04/2015 - 12/2010
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2023
1	Glycogen Storage Disease Type I 01/2023
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Adenocarcinoma of Lung 10/2020
1	Lobular Carcinoma 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Lymphatic Metastasis 01/2020
1	Fatigue 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Disease Progression 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Vomiting 01/2019
1	Nausea 01/2019
1	Esophageal Squamous Cell Carcinoma 10/2017
1	Esophageal Neoplasms (Esophageal Cancer) 10/2017
1	Rectal Prolapse 01/2017
1	Ascites 01/2017
1	Meigs Syndrome (Meig's Syndrome) 01/2017
1	Inflammation (Inflammations) 04/2015

Drug/Important Bio-Agent (IBA)

7	Estrogen ReceptorsIBA 02/2023 - 07/2006
5	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2005
5	Biomarkers (Surrogate Marker)IBA 07/2023 - 02/2011
5	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2013
5	Epidermal Growth Factor (EGF)IBA 07/2018 - 02/2011
4	Hormones (Hormone)IBA 01/2019 - 06/2012
3	Progesterone Receptors (Progesterone Receptor)IBA 02/2023 - 08/2015
3	Phenobarbital (Luminal)FDA Link 04/2021 - 01/2012
3	Messenger RNA (mRNA)IBA 10/2020 - 07/2010
3	LigandsIBA 08/2020 - 02/2011
3	human ERBB2 proteinIBA 07/2019 - 06/2014
3	AnthracyclinesIBA 07/2019 - 06/2018
3	Capecitabine (Xeloda)FDA Link 07/2018 - 01/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2024 - 01/2019
2	ParaffinIBA 01/2023 - 01/2019
2	eribulin FDA Link 07/2021 - 06/2018
2	taxaneIBA 07/2019 - 06/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2019 - 05/2014
2	Tamoxifen FDA LinkGeneric 01/2019 - 06/2014
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 12/2012
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 12/2012
2	Epirubicin (Ellence)FDA LinkGeneric 07/2018 - 01/2012
2	HMGB1 Protein (HMG1)IBA 04/2015 - 12/2010
2	Cetuximab (Erbitux)FDA Link 05/2014 - 01/2013
2	Transcription Factors (Transcription Factor)IBA 02/2012 - 01/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2012 - 01/2010
1	abemaciclibIBA 02/2024
1	palbociclibIBA 02/2024
1	Cyclin-Dependent Kinase 4IBA 02/2024
1	Proton Pump InhibitorsIBA 02/2024
1	Androgen Receptors (Androgen Receptor)IBA 02/2023
1	hypotaurineIBA 01/2023
1	polysulfideIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 01/2023
1	Glucose-6-PhosphateIBA 01/2023
1	beta-Aminoethyl Isothiourea (AET)IBA 03/2022
1	Circulating Tumor DNAIBA 09/2021
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 07/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2021
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	Indicators and Reagents (Reagents)IBA 10/2020
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2020
1	Aromatase InhibitorsIBA 08/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	PlatinumIBA 12/2019
1	Etoposide (VP 16)FDA LinkGeneric 12/2019
1	PolyaminesIBA 10/2019
1	Trastuzumab (Herceptin)FDA Link 07/2019
1	Vascular Endothelial Growth Factor DIBA 03/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2019
1	Vascular Endothelial Growth Factor CIBA 03/2019
1	Keratins (Keratin)IBA 01/2019
1	AntiemeticsIBA 01/2019
1	Olanzapine (Zyprexa)FDA Link 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Aprepitant (Emend)FDA Link 01/2019
1	Green Fluorescent ProteinsIBA 01/2019
1	E2F Transcription FactorsIBA 07/2018
1	Gemcitabine FDA Link 07/2018
1	Cytotoxins (Cytolysins)IBA 07/2018
1	Thymidylate SynthaseIBA 07/2018
1	Lapatinib (GW572016)FDA Link 07/2018
1	Dihydrotachysterol (AT 10)IBA 06/2018
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 10/2017
1	CaspasesIBA 10/2017

Therapy/Procedure

9	Therapeutics 03/2022 - 06/2010
8	Drug Therapy (Chemotherapy) 01/2020 - 04/2011
4	Neoadjuvant Therapy 07/2019 - 12/2012
3	Adjuvant Chemotherapy 01/2020 - 04/2011
1	Genomic Medicine 02/2021
1	Ovariectomy (Oophorectomy) 01/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	Cautery 01/2016